RxDoctor Payments DataLook up a doctor →

Scott Willoughby

Family · Meridian, IDNPI 1457897852

Payments from drug & device makers

$5,682in general payments, 2019–2025

Across 289 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$674
  • Amgen$446
  • AstraZeneca$438
  • Neurocrine Biosciences, Inc.$367
  • Novo Nordisk$332
  • Pfizer$283
  • plus $3K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie42$674
Amgen21$446
AstraZeneca21$438
Neurocrine Biosciences, Inc.17$367
Novo Nordisk18$332
Pfizer14$283
Lilly USA, LLC16$278
Teva Pharmaceuticals USA, Inc.10$239
Novartis11$196
Johnson & Johnson9$158
Mylan Specialty L.p.7$146
GSK7$144
E.r. Squibb & Sons, L.L.C.8$129
Otsuka America Pharmaceutical, Inc.5$108
Exact Sciences4$105
Idorsia Pharmaceuticals US Inc6$104
Boehringer Ingelheim6$101
Bayer4$90
Dexcom, Inc.3$84
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$77
Stryker2$66
Astellas Pharma US Inc3$66
Philips North America LLC2$61
Shield Therapeutics Inc3$60
Takeda Pharmaceuticals U.S.A., Inc.3$56
Nestle Healthcare Nutrition Inc.3$53
Merck3$52
Corcept Therapeutics2$50
Aimmune Therapeutics, Inc.2$48
Acadia Pharmaceuticals Inc2$42
Averitas Pharma Inc.1$42
Otsuka Pharmaceutical Development & Commercialization, Inc.2$41
Sumitomo Pharma America, Inc.2$41
Sunovion Pharmaceuticals Inc.2$39
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$37
Corium, LLC2$34
Sanofi Pasteur Inc.1$25
Xeris Pharmaceuticals, Inc.1$25
Alnylam Pharmaceuticals Inc.1$22
Abbott1$22
Kyowa Kirin, Inc.1$21
Esperion Therapeutics, Inc.1$21
Arbor Pharmaceuticals, Inc.1$20
Tanabe Pharma America, Inc.1$20
Regeneron Healthcare Solutions, Inc.1$19
Phathom Pharmaceuticals, Inc.1$19
Medtronic1$19
Hologic Sales And Service, LLC1$19
Biogen1$19
Sanofi-aventis U.S. LLC1$18
Ultragenyx Pharmaceutical Inc.1$17
Vanda Pharmaceuticals Inc.1$17
Kowa Pharmaceuticals America, Inc.1$15
Scilex Pharmaceuticals Inc.1$15
Boston Scientific1$14
Exeltis, USA Inc.1$13
Eisai Inc.1$12

How this compares

$5,682 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.

See all family providers in Idaho →

Medicare billing

Part B allowed, 2024
$61,758
Medicare patients
228
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Meridian

See the full list for Idaho →

Where these figures come from

Is this you, or does something look wrong? →